Martin J. Heidecker
Angel · Pennsylvania
Board director at 4 startups that filed Form D raises since late 2024, mostly in Pennsylvania.
- Stages
- Series B, Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Jun 2024
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Venatorx PharmaceuticalsFeb 27, 2023
- SEC Form D: Vedanta BiosciencesMay 2, 2023
- SEC Form D: Adaptive Phage TherapeuticsJun 9, 2023
- SEC Form D: Elion TherapeuticsJun 26, 2024
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.